Pregled bibliografske jedinice broj: 914798
Rebleeding rate and the need for blood transfusion in patients with upper gastrointestinal tumor bleeding are higher than in patients with peptic ulcer bleeding
Rebleeding rate and the need for blood transfusion in patients with upper gastrointestinal tumor bleeding are higher than in patients with peptic ulcer bleeding // United European Gastroenterology Journal Issue 5_suppl, 24th United European Gastroenterology Week Vienna, Austria, October 2016 Abstract Issue, October 2016 , pp. i–A754
Beč, Austrija, 2016. str. 673-673 (poster, međunarodna recenzija, sažetak, ostalo)
CROSBI ID: 914798 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Rebleeding rate and the need for blood transfusion in patients with upper gastrointestinal tumor bleeding are higher than in patients with peptic ulcer bleeding
Autori
Kralj, Dominik ; Budimir, Ivan ; Baršić, Neven ; Nikolić, Marko ; Jurčić, Petra ; Budimir, Ivan Yr
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo
Izvornik
United European Gastroenterology Journal Issue 5_suppl, 24th United European Gastroenterology Week Vienna, Austria, October 2016 Abstract Issue, October 2016 , pp. i–A754
/ - , 2016, 673-673
Skup
24th United European Gastroenterology Week
Mjesto i datum
Beč, Austrija, 17.10.2016. - 19.10.2016
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
upper gastrointestinal tumor bleeding ; upper gastrointestinal bleeding ; blood transfusion
Sažetak
Introduction: The aim of this study was to compare peptic ulcer bleeding (PUB) with upper gastrointestinal tumor bleeding (UGITB) while placing special emphasis on the incidence, outcomes including thirty-day re-bleeding rate, mortality and the need for blood transfusion. Aims & Methods: A total of 2198 patients referred to our Emergency Department with upper gastrointestinal bleeding (UGIB) were included in this prospective study during 5 years (from January 2008 till December 2012) ; 796 with PUB and 61 with UGITB, found during urgent upper GI endoscopy performed within 24 hours of admission. Results: Cumulative incidence of UGIB was 126/100000 in a 5-year period. 796(36.2%) patients had PUB and 61 (2.8%) patients had UGITB. UGITB was most often found in the stomach (58/95%) ; the tumors were dominantly malignant (55/90%), most of them adenocarcinoma (48/87.3%). Median age for PUB was 67, and for UGITB 76 years(p50.01). PUB and UGITB were more common in men (62.3% and 52.5%). Re-bleeding occurred more often in patients with UGITB(19.7% vs 9.7%, p50.01), but a higher number of patients with PUB required surgical intervention due to uncontrolled bleeding (5.9% vs 3.3% p50.01). Thirty-day mortality showed no difference between the two groups (5.2% vs 7.2%). Transfusion of red blood cells was administered more often in patients with UGITB (75.4% vs 49.5%, p50.01), while patients with PUB received comparably higher volumes of transfused red blood cells. Conclusion: Patients with UGITB have higher re-bleeding rates, require surgical intervention less often, and are more often treated with blood transfusion than PUB.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
KBC "Sestre Milosrdnice"
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus